(Q33893365)

29 July 2017

1 reference

title

Steroid-induced osteoporosis in systemic lupus erythematosus (English)

1 reference

systemic lupus erythematosus

29 July 2017

0 references

0 references

glucocorticoid-induced osteoporosis

1 reference

Cunnane G

1

1 reference

29 July 2017

Lane NE

series ordinal

2

1 reference

29 July 2017

publication date

1 May 2000

1 reference

Rheumatic Diseases Clinics of North America

29 July 2017

published in

1 reference

29 July 2017

volume

26

1 reference

29 July 2017

issue

2

1 reference

29 July 2017

page(s)

311-29, vi-vii

1 reference

Intermittent etidronate therapy to prevent corticosteroid-induced osteoporosis

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970140-X

7 January 2021

The prevention of corticosteroid-induced osteoporosis with nandrolone decanoate

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970140-X

7 January 2021

Effects of hydrochlorothiazide and dietary sodium restriction on calcium metabolism in corticosteroid treated patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970140-X

7 January 2021

Prevention of early postmenopausal bone loss using low doses of conjugated estrogens and the non-hormonal, bone-active drug ipriflavone

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970140-X

7 January 2021

Safety of hormone replacement therapy (HRT) in systemic lupus erythematosus (SLE)

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970140-X

7 January 2021

The role of calcitonin in the prevention of osteoporosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970140-X

7 January 2021

25 years of salmon calcitonin: from synthesis to therapeutic use

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970140-X

7 January 2021

Effects of ipriflavone and its metabolites on a clonal osteoblastic cell line

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970140-X

7 January 2021

Flavonoids: biochemical effects and therapeutic applications

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970140-X

7 January 2021

Calcium and vitamin D3 supplementation prevents bone loss in the spine secondary to low-dose corticosteroids in patients with rheumatoid arthritis. A randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970140-X

7 January 2021

Clinical review 83: Mechanisms of glucocorticoid action in bone: implications to glucocorticoid-induced osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970140-X

7 January 2021

Effect of glucocorticoids on type I collagen synthesis, alkaline phosphatase activity, and deoxyribonucleic acid content in cultured rat calvariae

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970140-X

7 January 2021

Differential effects of continuous and transient treatment with parathyroid hormone related peptide (PTHrp) on bone collagen synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970140-X

7 January 2021

Effects of thiazide diuretic therapy on bone mass, fractures, and falls. The Study of Osteoporotic Fractures Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970140-X

7 January 2021

Cortical osteoclasts are less sensitive to etidronate than trabecular osteoclasts

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970140-X

7 January 2021

Hormonal status in normal, osteoporotic and corticosteroid-treated postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970140-X

7 January 2021

The influence of prednisone on the muscle morphology and muscle enzymes in patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970140-X

7 January 2021

A controlled trial of the effect of calcium supplementation on bone density in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970140-X

7 January 2021

Pamidronate and uveitis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970140-X

7 January 2021

Esophagitis associated with the use of alendronate

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970140-X

7 January 2021

Bone histomorphometry in glucocorticoid-induced osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970140-X

7 January 2021

Longitudinal study of hand bone densitometry in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970140-X

7 January 2021

Retrobulbar optic neuritis after pamidronate administration in a patient with a history of cutaneous porphyria

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970140-X

7 January 2021

Cyclical etidronate plus ergocalciferol prevents glucocorticoid-induced bone loss in postmenopausal women.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970140-X

7 January 2021

Effect of oral 1,25-dihydroxyvitamin D and calcium on glucocorticoid-induced osteopenia in patients with rheumatic diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970140-X

7 January 2021

Abnormal bone mineralization after fluoride treatment in osteoporosis: A small-angle x-ray-scattering study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970140-X

7 January 2021

Side-effects of pamidronate

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970140-X

7 January 2021

Studies of the oral bioavailability of alendronate.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970140-X

7 January 2021

Ultrasound parameters in osteoporotic patients treated with salmon calcitonin: a longitudinal study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970140-X

7 January 2021

Generalised bone loss in patients with early rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970140-X

7 January 2021

Effects of chronic prednisolone treatment on bone resorption and bone composition in intact and ovariectomized rats and in ovariectomized rats receiving beta-estradiol

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970140-X

7 January 2021

In vitro detection of neutralizing antibodies after treatment of Paget's disease of bone with nasal salmon calcitonin.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970140-X

7 January 2021

Effective therapy of glucocorticoid-induced osteoporosis with medroxyprogesterone acetate

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970140-X

7 January 2021

In corticosteroid-treated respiratory diseases, monofluorophosphate increases lumbar bone density: a double-masked randomized study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970140-X

7 January 2021

Effects off short term glucocorticoid administration on intestinal calcium absorption and circulating vitamin D metabolite concentrations in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970140-X

7 January 2021

Altered mineral metabolism in glucocorticoid-induced osteopenia. Effect of 25-hydroxyvitamin D administration

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970140-X

7 January 2021

Effect of hormone replacement therapy on bone mass in rheumatoid arthritis patients treated with and without steroids

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970140-X

7 January 2021

The response of vertebral bone mineral density during the treatment of osteoporosis with sodium fluoride.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970140-X

7 January 2021

Glucocorticoid inhibition of FSH-induced estrogen production in cultured rat granulosa cells

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970140-X

7 January 2021

Corticosteroid and bone

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970140-X

7 January 2021

Insulin-like growth factor I stimulates bone turnover in osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970140-X

7 January 2021

Postprandial parathyroid hormone response to four calcium-rich foodstuffs

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970140-X

7 January 2021

Retention of etidronate in human, dog, and rat

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970140-X

7 January 2021

Bone mineral status in growth hormone-deficient males with isolated and multiple pituitary deficiencies of childhood onset

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970140-X

7 January 2021

Fluorides and osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970140-X

7 January 2021

Differential effects of glucocorticoids on cortical appendicular and cortical vertebral bone mineral content

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970140-X

7 January 2021

The science and therapy of glucocorticoid-induced bone loss.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970140-X

7 January 2021

Parathyroid hormone treatment can reverse corticosteroid-induced osteoporosis. Results of a randomized controlled clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970140-X

7 January 2021

Rheumatoid arthritis and bone mineral density in elderly women. The Study of Osteoporotic Fractures Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970140-X

7 January 2021

The role of estrogen in the prevention of osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970140-X

7 January 2021

Acute effects of pamidronate administration on serum levels of interleukin-6 in advanced solid tumour patients with bone metastases and their possible implications in the immunotherapy of cancer with interleukin-2

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970140-X

7 January 2021

Bone loss after glucocorticoid therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970140-X

7 January 2021

Glucocorticoid-Induced Osteoporosis: Pathogenesis and Management

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970140-X

7 January 2021

Estrogen and progesterone replacement therapy reduces glucocorticoid-induced bone loss

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970140-X

7 January 2021

Serum osteocalcin is increased in patients with hyperthyroidism and decreased in patients receiving glucocorticoids

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970140-X

7 January 2021

Reduction of serum testosterone levels during chronic glucocorticoid therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970140-X

7 January 2021

Bone marrow, cytokines, and bone remodeling. Emerging insights into the pathophysiology of osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970140-X

7 January 2021

Stimulation of bone formation in osteoporosis patients treated with fluoride associated with increased DNA synthesis by osteoblastic cells in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970140-X

7 January 2021

Clinical utility of bone mass measurements in adults: consensus of an international panel. The Society for Clinical Densitometry

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970140-X

7 January 2021

Prevention of corticosteroid-induced osteoporosis with salmon calcitonin in sarcoid patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970140-X

7 January 2021

Intermittent cyclical etidronate in the prevention of corticosteroid-induced bone loss

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970140-X

7 January 2021

The effects of recombinant human insulin-like growth factor (rhIGF)-1 and rhIGF-1/IGF binding protein-3 administration on rat osteopenia induced by ovariectomy with concomitant bilateral sciatic neurectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970140-X

7 January 2021

Calcium and osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970140-X

7 January 2021

Effect of salcatonin given intranasally on early postmenopausal bone loss

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970140-X

7 January 2021

Erythroderma after clodronate treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970140-X

7 January 2021

Treatment of Postmenopausal Osteoporosis with Slow-Release Sodium Fluoride: Final Report of a Randomized Controlled Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970140-X

7 January 2021

Effect of ipriflavone on bone mass in elderly osteoporotic women

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970140-X

7 January 2021

Intact parathyroid hormone levels are not elevated in glucocorticoid-treated subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970140-X

7 January 2021

Effects of two treatment regimes with synthetic human parathyroid hormone fragment on bone formation and the tissue balance of trabecular bone in greyhounds

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970140-X

7 January 2021

PTH: a future role in the management of osteoporosis?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970140-X

7 January 2021

Prevention of osteoporosis with nasal salmon calcitonin: effect of anti-salmon calcitonin antibody formation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970140-X

7 January 2021

The roles of calcium and vitamin D in the prevention of osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970140-X

7 January 2021

Lateral spine densitometry is a more sensitive indicator of glucocorticoid-induced bone loss

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970140-X

7 January 2021

Bone mineral density of the proximal femur and lumbar spine in glucocorticoid-treated asthmatic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970140-X

7 January 2021

Salmon calcitonin reduces vertebral fracture rate in postmenopausal crush fracture syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970140-X

7 January 2021

Effect of the fluoride/calcium regimen on vertebral fracture occurrence in postmenopausal osteoporosis. Comparison with conventional therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970140-X

7 January 2021

Salmon calcitonin in the therapy of corticoid-induced osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970140-X

7 January 2021

Bisphosphonates: mechanisms of action

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970140-X

7 January 2021

Bisphosphonate-induced bronchoconstriction in aspirin-sensitive asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970140-X

7 January 2021

Effects of human growth hormone in men over 60 years old

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970140-X

7 January 2021

Corticosteroid-induced bone loss. A longitudinal study of alternate day therapy in patients with bronchial asthma using quantitative computed tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970140-X

7 January 2021

Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis. Glucocorticoid-Induced Osteoporosis Intervention Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970140-X

7 January 2021

Inhibition of Luteinizing Hormone Secretion Induced by Synthetic LRH by Long-term Treatment with Glucocorticoids in Human Subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970140-X

7 January 2021

Determinants of axial bone loss in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970140-X

7 January 2021

Prevention of corticosteroid osteoporosis. A comparison of calcium, calcitriol, and calcitonin

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970140-X

7 January 2021

Ultrasound discriminates patients with hip fracture equally well as dual energy X-ray absorptiometry and independently of bone mineral density

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970140-X

7 January 2021

Enhanced prostanoid release from monocytes of patients with rheumatoid arthritis and active systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970140-X

7 January 2021

Changes in bone histomorphometry after long-term treatment with intermittent, cyclic etidronate for postmenopausal osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970140-X

7 January 2021

Cyclical etidronate reverses bone loss of the spine and proximal femur in patients with established corticosteroid-induced osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970140-X

7 January 2021

Importance of increased urinary calcium excretion in the development of secondary hyperparathyroidism of patients under glucocorticoid therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970140-X

7 January 2021

Spontaneous production of bone-resorbing lymphokines by B cells in patients with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970140-X

7 January 2021

Not all postmenopausal women on chronic steroid and estrogen treatment are osteoporotic: predictors of bone mineral density

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970140-X

7 January 2021

An open study of dehydroepiandrosterone in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970140-X

7 January 2021

Inhibition of collagen and sulfated glycosaminoglycan synthesis in neonatal mouse dermal fibroblasts by corticosterone

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970140-X

7 January 2021

Bisphosphonates induce osteoblasts to secrete an inhibitor of osteoclast-mediated resorption

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970140-X

7 January 2021

Treatment of osteoporosis with bisphosphonates

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970140-X

7 January 2021

Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970140-X

7 January 2021

10.1016/S0889-857X(05)70140-X

Identifiers

DOI

1 reference

29 July 2017

1 reference